Aurora licensing

About us

The Aurora group includes AURORA LICENSING, a company that manages national and international patents and trademarks, and Aurora Biofarma, which manages commercial activities; since 2019, a new Export Department has been established in the AURORA LINCENSING, in order to be competitive and engage international activities.

Therefore, the AURORA GROUP has also profit sharing in develop & research companies.

Timeline

2010

Aurora Biofarma was born in 2010, as an innovative business dedicated to the research, development and marketing of nutraceuticals and medical devices

2014

The company is proud to get an AAA rating, according to the BASILEA 3 criteria, with company’s profits constantly invested which enabled to grow up year by year

2017

In the 2017 the company entered in the pharmaceutical sector in order to finalize a solid structure made by the Human Department and Veterinary Department

2018

Aurora Biofarma closed the 2018 in the domestic market with the goal of 20 millions Euro income and a forecast grow of + 35% comparing with the previous year

2021

Aurora Biofarma becomes a pharmaceutical company with AIC ownership

2023

Consolidation of leadership position in the target market

Future

Which will lead the entire team to anticipate the challenges of the future

MEASURING VALUES
Human values are, for example, respect, acceptance, consideration, appreciation, listening, openness, affection, empathy.


OUR INNOVATIONS
Technological products innovation are visible parts of AURORA LICENSING, which has been described as a smart choice for an innovative start up; Italian quality & creativity are tangible in the high level of our products range. Medical devices, nutraceuticals, dietary food, complementary feed for dogs and cats playing a top player part in the Italian market.



TEAM INTEGRITY
Integrity and transparency are the principles that guide AURORA LICENSING’s action in formulating a management and control structure that is suited to its size, in adopting an effective internal control and risk management system, and in communicating with shareholders and other stakeholders, also by reviewing and updating the information on its website.